Full-Time

Fixed-Term

Manufacturing Associate I, Drug Substance

Posted on 9/16/2024

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Biotechnology
Healthcare

Entry, Junior

Oxford, UK

This position is site-based, requiring full-time presence at Moderna’s site.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary

You match the following Moderna's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • 1+ years of experience in a GMP manufacturing environment
  • A university degree with a specialization in Pharmaceutical production technology or equivalent
Responsibilities
  • Ensuring safety and compliance with Moderna’s procedures and health regulations.
  • Performing and documenting routine manufacturing operations.
  • Participating in quality assurance activities and continuous improvement initiatives.
  • Collaborating effectively within a dynamic, cross-functional team environment.
  • Maintaining and troubleshooting equipment and digital tools.
  • Engaging in root cause analysis and corrective action plans.
  • Supporting the team in achieving operational excellence and meeting KPIs.
Desired Qualifications
  • Experience with filtration and chromatography, and cold chain management a plus
  • Experience in audit / inspection preparation, understanding Health authority and regulatory guidelines
  • Ability to collaborate fluidly with peers, leadership and cross-functional support groups required
  • Excellent written, oral communication, and organizational skills required.
  • Ability to maintain attention to detail while executing multiple tasks with minimal supervision
  • Demonstrated commitment to Moderna's values of Bold, Collaborative, Curious, and Relentless, embodying these values in the workplace

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treatment options for various diseases. Unlike traditional pharmaceuticals that often rely on proteins or antibodies, Moderna's mRNA-based therapies can be designed and manufactured more rapidly, allowing for quicker responses to emerging health challenges. The company's goal is to harness the power of mRNA to improve patient outcomes and transform the landscape of medicine.

Company Stage

IPO

Total Funding

$6.5B

Headquarters

Cambridge, Massachusetts

Founded

2010

Growth & Insights
Headcount

6 month growth

0%

1 year growth

2%

2 year growth

4%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna awarded $590 million for bird flu vaccine development.
  • Moderna's mRNA technology expands into oncology and rare diseases.
  • Moderna's EU tender diversifies COVID-19 vaccine supply.

What critics are saying

  • Increased competition from BioNTech and Pfizer in mRNA vaccines.
  • Potential public skepticism reduces COVID-19 vaccine demand.
  • Regulatory challenges in obtaining approvals for new mRNA vaccines.

What makes Moderna unique

  • Moderna is pioneering mRNA as a new class of medicines.
  • Moderna's mRNA platform enables rapid development of vaccines and therapeutics.
  • Moderna's collaboration with AI firms enhances drug discovery processes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

401(k) Company Match

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

INACTIVE